Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In 2024, there were 8.4 million prescriptions and $8.6 billion in spending on GLP-1s in Medicaid, and 21.8 million claims and $27.5 billion in gross spending (not excluding rebates) on GLP-1s in Medicare (Figure 1)
Clinical trial data for women: A 2025 analysis of the SURMOUNT trials specifically looked at whether reproductive stage (premenopausal, perimenopausal, postmenopausal) affected weight loss with tirzepatide
Were here for you
Cell Mol Biol (Noisy-le-Grand)
June 2026: a third wave of 25 warning letters lands during the week of June 15, again citing claims that a compounded product is the "same" as the FDA-approved drug, plus marketing that never discloses which pharmacy actually made it
Irritable bowel syndrome and stress-related psychiatric co-morbidities: focus on early life stress
US$ 26.15
US$ 29.15
US$ 22.43
US$ 21.14
